OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-03-31-accounts

Healthcare InFection Society • o o• •oOO oooo 0000 0000 0000 0000 oooo o•oo o•0 OOO Annual Report o O O O For theyear ended 31 March 2022 000 000 o o o • Charity number 1158172

Contents Chair's statemÈnt Trustees, report 13 Plans For 2022-2023 Financial reviow 13 Who are we? Our income 13 Our hislory What do we want to achieve7 Our expendilure Managing our reserves 14 Our objectives Our statements oFpurpose Pensions 15 Fulure viability considerations 15 How do we deliver ouractivities? Ourprogress 2021-2022 15 Ourslrategy For 2020-2025 Our research Membership 15 Communications 15 Ourjournals Evenls and educalion 16 Our educational programme Howdowe raise Funds7 Educational resources 18 10 Who are ouraudience, supporter5 and team7 10 Exfprnal pvg.nl. 18 Our mernbers 10 H15 iournals 18 Our volLJnteers 10 The science of IPC 21 Our Learn 10 Clinical guidelines and guidance 21 Why arewe needed? 11 Guidelirles published 22 The challenges our rnembers Face Public benefit Grants and bursaries 22 Rescinding of granls Our impact 12 Our headquarlers 24 OS 2021 17 20

Our plans For 2022-2023 25 Land and property 32 Membership engagernenl 2.5 External collaboralions 32 Equality, diversity and inclusion 25 Risks and uncertainLies Training and education 25 Principle risks 34 Social modia 26 Challenges during the year 35 Podcast.. Infection P￿vention in Converst7tion 2fi 5laFThome working and wellbeing 35 Ourjournals 26 Volunleer engagement 35 Journal ofH05Pltal Infection 26 Cancelled events 35 Infection Prevention in Pructice 26 New premises 35 Guideline production 27 Remuneration and grant making Research and grant Funding 27 Remuneration Committee 36 Income diversification 27 Key management personnel remuneraLion Our governance 28 Statement of triJ5tees' responsibilities 37 Governance structure and managemenL 28 Independent auditor's report to the trustees oFthe Healthcare InFection Society Council and Commitlees 28 38 Governance reviews 2g Statement oFfirbancial activities 41 Thp. C7fJve.rnanc.p C.nde. 30 Balance sheet 42 Equality, diversiLy and inclusion.. developing a slralegy Statement oFcash Flows 43 30 Notes to the accounts 44 Organisational structure and decision-making process Reference and administrative inFormation 52 uality, diversi 'nclusion.- 30 32

Healthcare Infection Society Annual Report

Chair’s statement

As the Society’s new Chair, I am delighted to be able to share with you this report from the Trustees of the Healthcare Infection Society (HIS) for the 2021–2022 �nancial year.

My role as Chair began in November 2021 when I took over from Elisabeth (Lisa) Ridgway. Lisa was Chair for two consecutive terms and the Society is extremely grateful to Lisa and to Peter Jenks, who also stepped down in Novemberafterserving two terms as Honorary Secretary.

Unsurprisingly, the Society and its members are still managing the impact of the COVID-19. However, despite the numerous challenges associated with the outbreak, there have been many positives.

The transition to online delivery of our education and training during the pandemic has allowed us to reach larger and more diverse audiences. As such, virtual events have now become the norm and our training and education programme now includes three distinct and permanent webinar series.

During the year, our planned programme of events included three online Trainee Education Days, each attended by between 194 and 287 of the Society’s 480 Trainee members. After cancelling two Directors of Infection Prevention and Control (DIPC) events in 2020 because of di�culties securing speakers during the pandemic, it was gratifying that two DIPC Development Days went ahead online in June and December,witha hybridevent planned forJune 2022 to take place in London and online. In June 2021 the Don’t Panic! conference took place, organised in association with the Infection Prevention Society (IPS), and was attended by 135 delegates.

As we demonstrated during 2020-2021, while some educational events were relatively straightforward to convert to a virtual format, others were not. The �ve-day HIS/UK Health Security Agency (UKHSA) Foundation Course in Infection Prevention and Control (IPC)was particularlydi�cult, because ofits interactive nature.

In April 2021, after a hiatus of more than a year, and after a huge amount of work from the convenors, it

was delivered virtually for the �rst time. In addition to the high-quality, expert-led presentations, the course included interactive workshops and real-life scenarios. The demand for this course, which has run since the 1980s, increases every year. Although online delivery ofthe event meanswe can accept more attendees than usual, the live interactive sessions are a crucial part of the learning experience and can only be managed by capping the numbers.

Consequently, despite accommodating 50 delegates for each event in April, December, and February 2022, more than 100 remain on the waiting list. During 2022 we will work with UKHSA to revise the format of this event to ensure we are able to reach more IPC specialists.

In September, as national COVID-19 restrictions were relaxed, and afterthe implementation ofCOVID-secure measures, the trustees approved a phased return for sta�to on-site working at our headquarters, Montagu House. September saw the sta�team back in the o�ce and the start of face-to-face meetings and events.

The 150th Council meeting took place as a hybrid event, with some trustees attending in person and others attending virtually, and in September and November Tim Boswell and Nik Mahida delivered the OutbreaksTrainingCoursetoasmallgroupofdelegates in Montagu House. The Eastwood Park Engineering Aspects ofInfection Control Course, which could not be converted to a virtual format because of its hands-on nature, returned in a conventional face-to-face format in October. Eleven delegates (compared to the usual 16) attended to ensure that appropriate distancingwas possible during all sessions.

Guideline and guidance production remains one of the Society’s key activities: �ve clinical guidelines were completed and published during the year. We are grateful to our Working Parties and to the sister societies who have worked so hard to ensure these guidelines were produced.

4

For the year ended 31 March 2022

To help facilitate their implementation and discovery, a new webinar series, Spotlight on Guidelines, and educational resources were delivered to coincide with publication. The webinars were audience-led and providedaplatformforattendeestoquestionmembers of the Working Party.

We were delighted to announce that the Journal of Hospital Infection’s (JHI) impact factor (2020) had risen from 3.271 to 3.926 – the highest JHI impact factor to date. This was particularly pleasing given the unexpected fall in 2019, and was accompanied by other positive journal metrics that give an insight into our impact on the scienti�c community. On behalf of the Society, I would like to express my thanks to Jim Gray, the JHI Editor in Chief, and all the journals team, for their work over the last year. Their unfailing commitment, professionalism, and enthusiasm in dealing with the massively increased workload arising from the pandemic have been extraordinary.

Oursecond journal, Infection Preventionin Practice (IPIP) was launched in 2019 as a fully open access online publicationandinAugust2021wereceivednoticethat, following a rigorous evaluation process, IPIP had been successfully indexed in PubMed Central. We are hugely grateful to IPIP’s Editor in Chief Gemma Winzor and the IPIP team fortheircommitment to IPIP’s success, and to everyonewho has published in IPIP in the last twoyears in support of this new publication.

Plans for 2022–2023

Over the next few years, our main source of income, namelythatfrom theJHI,is likelytodecline. To allowHIS to keep on delivering courses and meetings, producing guidelines, supporting research, and publishing the journals, new funding will need to be found. Identifying suitable sources of income has been, and remains, a priorityforthe Society.Whatever2022 and subsequent years bring, HIS will adapt and continue to support healthcare professionals to manage, prevent and control healthcare-associated infections (HCAIs).

I would like to thank our fellow trustees and Council members, the volunteers on Committees and Working Parties,thejournaleditors,andtheSocietysta�fortheir

commitment to HIS over the last year. The pandemic has been a gruelling time for IPC and challenges undoubtedly remain. Despite the ongoing pandemic, the Society has remained resilient and managed to support its members and the wider IPC community through the delivery of new and reformatted online events and courses, and with the massive output from the journals.

I cannot thank those who have contributed their time and e�ort, when under such sustained pressure from COVID, enough.

On a �nal note, we look forward to being able to �nally celebrate our 40th anniversary (two years later than planned) in May 2022. This event will highlight the achievements of the Society since it was formed in 1980 and look forward to the future.

Dr Chris Settle, Chair of Trustees

Christopher Settle (Nov 3, 2022 09:20 GMT)

5

Healthcare Infection Society Annual Report

Who are we?

HIS is a membership organisation and learned society. HIS delivers activities and initiatives to support healthcare professionals to manage, prevent and control nosocomial (healthcare-associated) infections.

Many patients acquire HCAIs either as a result of being in contact with a healthcare setting or via medical interventions. IPC is therefore a priority for those working in patient-facing healthcare.

Our history

The Society was formed by a group of consultant medical microbiologists in 1980. Their vision was to create anorganisation thatwould nurture and promote the scienti�c interests of hospital doctors who were interested in nosocomial infections.

First registered as a charity named ‘Hospital Infection Society’ in January 1983 (No. 286064), HIS became a Charitable Incorporated Organisation (CIO), charity number 1158172, in 2014.

Since inception, the Society has been governed by a board of trustees and O�cers who, along with Committee Chairs and Co-opted members, serve as the HIS Council. The membership was originally largely clinical, but today membership is open to those interested in furthering the Society’s objectives: members fall into the categories of Full, Associate, Trainee, Associate Trainee and Emeritus membership, dependingonprofessionalandacademicquali�cations, and the member’s professional role in IPC.

The category of Honorary membership is awarded by Counciltoanindividualinrecognitionofanoutstanding and unique contribution to the Society, over and above that which might normally be delivered by holding a Societyrole or o�ce, or through involvement in Society activities. One founding member, David Shanson, remains a member today. David was awarded Honorary membership status and the HIS Gold Medal in 2020.

Founder Member, David Shanson

6

Foriheyearended31 March2021 What do we want to achieve? Our objectives journals, we commynicaie new developments and best practice within IPC. The Society aims to support educational initiatives which improve IPC practice, and to ￿d￿Ce the leve of preventable HCAls in existence. Through our events, online resources. Funded research and scientific We workto reach a global community of IPC specialists nd non-specialists to bring the benefiLs of the best IPC practice to patients and thereby improve the ca Fall patients for the public benefit. Preventing HCAIS by supporting research, evidence nd besl practice. Offering expert guidance in the prevention and control OFHCAIS. Supporting everyone Striving to inspire and in UKhealihcare support generalion5 and around the of IPC professionals world to redu through training. avoldable HCAIS. education and rnllAhnraf.Inn Communicating Jioneering world- leading research. driving effective pracLice. Ourstatements oFpurpose OURVISION OUR MISSION OUR VALUES To provide healthcare professionals with the inforrnalion. evidence and skills they need to prevent and control HCAIS. Aworld in which HCAIS have been reduced to thè lowest P055ible level. Good Science underpins good clinical practice. Continual professional leaming and development is necessary toreduce th4incidence of HCAI Many HCAis are preventable through effective multidisci>linaryteamwo Collaborationwithi and beyond the knety will help to advance and communicate knowledg&

Healthcare hfecUonSocletyAnnu•l R¢port How do we deliver our activities? Our strategy For 2020-2025 to ensure they are achieved, Currently. the strategic objectives a￿ met by sharing research. evidence and best practice via a programme OF training and events, the development OF resources. the production DF evidence-ba5ed publications and guidance, the allocation oFresearch FL*nding. and otheractivities that support and represent HIS members. The 2020-2025 strategy Focuses on activities which support HIS members to overcome the professional challenges they Face, and which advance research that Lbnderpins excellence in clinical practice. The membership is consulLed regularly, and every five yeats a Formal strategy ￿VIeW takes place to ensu that HIS is up to date with the current climate within the field of nosocomial infection, the needs ofmembers and the needs OF the larger IPC community. On this basis, strategic objectives are set and plans developed Society activities are assessed quarterly during meetings OF HIS Council, and progres5 towards the delivery of key objectives is reviewed each November. In March 2022 HIS Council and the staFF team met to conduct a full review of progress to date and to assess next steps. Our strategy Growand engage Wèwill growourmembership. and engage and Support ourmembers. ProFessional development We wlll de.sign and deliver a range of expert-led educational activities. grants and re50urce5 that will promote the application of dinical best practice. equip healthcare proFession81s to reduce the levels oFHCAIs. and educate and inForm the public. Research and guidelines We will 511PPOrt, devolop and communiote research Foeused on IPC thatwill evidence best cliftical practice and promotè patient safety. Collaborate We will tollaboratewith like-minded oryanisations to promote be￿ prartice and inFlueno key opinion leaders. safeguard We will safeguard our future through investment and dlversification. We will do this by: • Building a robust and 5uthinable b￿sIneSS model to ensure financial security, continuity and the exploration of new opportunlties. • Valuing and 5upportingour5talY,volunteersand mefflbers.

Foriheyearended31 March2021 Our research In collaboration with the UKHSA, HIS runs a five-day standalone Foundation Course in IPC.Thecourse covers many topia related to controlling HCAls, including surveillance, outbreak investigation, hospital hygiene and antimicrobial resistance. and enable5 medical trainees. newly appointed consultants and other practitioners such as nurses and clinical scientists to oain a fim grounding in IPC. The Sociely Funds research in hospitals, ￿searCh InstitutÈs and univÈrgities within thÈ UK. Collaboration between clinician5, academics and expert5 From different disciplines is key to producing robust, evidence-based research that informs clinical best practice and improves patient outcomes. HIS aims to support researchers at ditrerent stages or their careers.. in December 2020 the research strategy was published to define priority Funding a￿as. Funding is reviewed regularly to ensu￿ it is fit For purpose for both the Society and the research community. HIS is a member of the Association For Medical Research ChaTitie5 IAMRCI. The one-day Outbreaks Training Course, aimed at senior members of IPC team5 who currently work in, or plan to move to, a role leading HCAI outbreak management. combines taught and practical sessions with opportltnities For dialogue around outbreak management. For those who wish to develop a deeper understanding OF aspects OFIPC Whe￿ engineering criteria are a vital component, the five-day, Fully-residential Engineering Aspects of Inffection Control includes session5 on specialist ventilation such as that of operating theatres, thermal (surgical instrument) and chemical (endoscope) washer-disinfectors, steam sterilisers, healthcare laundry and other aspects of hospitsl hygiene and decontamination. Ourjournals HIS publishes two internationally respected journals in collaboralion with Elsevier.. the IHI and IPIP. The JHI was Founded with the Society in 1980 and has served to publish and promote research in IPC and medical microbiology since that time. IPIP was launched in 2019 as a gold open access companion journal to the IHI and has a strong focus on localised outbreaks and IPC in lower- and middle-income countries. To support current or aspiring DIPCS, the Society runs a DIPC Networkand Development Programme oFone- day events that provide information, guidance and training around HCAls and a chance to network with key IPC proFessionals. The programme comprises series oFtwo independent, one-dayevents peryearover The Society develops and delivers training events and a three-year period, with tOPlCs reflecting the current resources aimed at all those who work in IPC both challenges Faced by thoseworking in a DIPC role. within the UK and globally. Oureducational programme HIS also runs regular webinars and an annual Spring Meeting on specialist topics, as well as hosting the Federation OF Infection Societies IFISI International Conference every iwoyears. The Trainee Education Programme is aligned to the Combined Infection and Higher Specialty Training curriculum and is open to all trainees regISte￿d on or considering inFecfion specialty training. The Programme comprises a series of three independent. one-day training sessions per year. over a three- year period. I FEDERATION OF INFECTION SOCIETIES

Healthcare Infection Society Annual Report

How do we raise funds?

HIS generates income through charitable activities including journal publication, conferences, training and educational events and membership.

Additionally, the Society has managed investment funds and rental income from two �oors of the HIS headquarters, Montagu House.

Who are our audience, supporters and team?

Our members

Thankyou to:

HIS Council

The membership is formed of individuals who are committed to reducing HCAI to the lowest possible level.

HIS has over 1,300 members, drawn largely from the medical profession. Theyare predominantlyconsultant microbiologists and doctors enrolled on infection specialty training programmes.

Nurses, clinical scientists, research scientists and others with a demonstrable professional interest in HCAIs are also a vital part of the membership network.

HIS is currently UK-focused, with 85% of members based in England, Scotland, Wales and Northern Ireland. However, everyone with an interest in HCAIs, wherever they are located, can access the Society’s education resources and publications.

Our volunteers

Our team

The HIS sta�team is comprised of nine individuals who, since September 2021, have worked to a hybrid model from HIS headquarters in London and from their homes.

In response to government guidance, during the period covered by this report, all members of the team worked exclusively from home during periods when it was advised by the UK Government to do so.

As a charity, the Society is governed by a Board of Trustees, the HIS Council. Area-speci�c Committees and Working Parties (all of whom are committed volunteers)guideandworkcloselywiththeexperienced sta�team. Volunteers help HIS to deliver all activities, from training events to the production of guidelines.

HIS would like to thank all the volunteers who, during 2021 and 2022, despite being under intense pressure, continued to donate time and share their expertise and experiences so that the Society could continue to deliver a wide range of publications and activities.

10

For the year ended 31 March 2022

Wh are we needed? y

HCAIs pose a serious risk to patients, sta�and visitors in healthcare settings. These infections can incurmajor costs for the NHS and healthcare systems worldwide, and cause signi�cant morbidity to those infected. Excellent IPC is a key priority for Society members, for governments and forhealthcare systems, and is vital to protect public health.

HIS members save patient lives and are committed to professional excellence. They are leading experts in HCAI and IPC, and theychampion clinical best practice. HISmembers in�uence thebehaviouroftheirpeersand they drive change, but they face signi�cant challenges in their roles as healthcare professionals on the frontline of patient care.

During the COVID-19 pandemic, the importance of IPC in community and healthcare settings became universally accepted as being a critical component of public health protection.

The challenges our members face

Within the context of HCAIs, HIS members face many challenges:

have led to less exposure to IPC during training.

Public bene�t

By providing evidence and guidance to help healthcare professionals to prevent and control HCAIs, the Society bene�ts the public through the advancement of health and the saving of lives.

The Society provides public bene�t through:

This report demonstrates how the Society’s charitable funds for the reported year were distributed and spent, andthebene�tsandimpactofthisontheadvancement of medical research and clinical practice.

The COVID-19 outbreak and the 2022 monkeypox outbreak have highlighted the importance of high standards ofIPC incommunityand healthcare settings, and HIS will continue to ensure that healthcare professionals are supported to acquire the knowledge andskillsnecessarytodeliverexcellentclinicalpractice.

The Society has referred to the Charity Commission’s guidance on public bene�twhen reviewing its aims and objectives and in planning for future activities.

The trustees con�rm that HIS has complied with its duty to have regard for the guidance on public bene�t published by the Charity Commission on exercising its powers and duties.

11

Healthcare hfecUonSocletyAnnu•l R¢port Our impact Event attendees JHI impact Factor 3.926 1374 Trainee education days (x3) 650 Submissions Articles accepted Downloads Outbreaks training courses (x3) JHI JHI 267 1J26 737,092 Foundation courses (x3) 153 Engineering courses (x1) 11 Ipip Ipip Ipip 136,955 161 DIPC days (x2) 142 Don't Panicl Membership 130 1,389 Total Webinars (x8) 1,202 Full 80 Trainee Grant funding Eight different gronts. rnngingfrom £750 travelgrants to £100,OOfor o three-yearmajor Research Grant. Associate Associate Trainee Memb¢rshlp growth this year Applications 14 42 Emeritus +170/ Grants awarded Honorary Total funding awarded £101,286 12

Foriheyearended31 March2021 Trustees, report In this report, the trustees present their annual report and Rnancial statements for the year ended 31 March 2022. These have been prepared in accordance with FR5102 and the Charities SORP 2015. Howwegenerated Funds Financial review The Society continues to be in a robust financial position with total Funds of £9m as at 31 March 2022 12021- £9.2ml. Journal publications Events £451.000 £114000 The deficit For the year oF£154k12021,' £443k surplus) comprises an operational defieit OF £144k 12021., operational surplus of £1 kl, together with imiestment losses of £10k12021: investment gains of £442kl, Investments Further details are given in the Statement OF Financial Activities on page 47, the Balance Sheet on page 42 which form part OF these financial statements, and the a5sociaLed notes to the financial statements. Membership Afflovntroi5C AmotrTrl ro15C £127,000 £52.000 Whatwefunded Ourincome The Society's income ￿ generated through charitable activities- educational events and membership, journal publications, conFerences, as well as through managed invpEFmpnt fiJnd< And rpntrAI inrnmp Frrtm trpnAnF¢ x Montagu House. Research and guideltnes Research grants Ourexpenditure £223.000 £157.000 Charitable activities HIS'S income is used to fund the Society s charitable objectives, which are met through charitable activities in the field OF IPC, These include journal publications, conFerences, education, research and guidelines, grants and awards and membership. 11 Conferencesand educational events Communications £275.000 £90 000 Income is also used to support the professional developmentoFHIS Council and thestaff team through a programme oFtraining. Membership activities

Healthcare Infection Society Annual Report

Managing our reserves

It is the policy of Council to maintain su�cient funds for the Society to meet its objectives and obligations on an ongoing basis. Society funds of £9m as at 31 March 2022 (2021: £9.2m) are all unrestricted funds.

Designated funds

The trustees continue todesignatefundsinaccordance with the Society’s �nancial strategyto ensure su�cient funding for ongoing Society activities and objectives, and to safeguard against expected or potential contingencies. Designated funds as at 31 March 2022 amounted to £8.3m (2021: £8.4m). These include the addition of a £3m Future Sustainability Fund for investment in income diversi�cation to underpin the Society’s �nancial sustainability. Designated funds are further explained in note 17 to the accounts.

Reserves policy

Operating reserves represent free reserves and are calculated after deducting designated funds from total Society funds. In line with the current HIS reserves policy, operating reserves are held to ensure the �nancial stability and ongoing operations of the Society in the event of an unanticipated loss in income or unexpected rise in expenditure.

The reserves policy, as determined by Council, sets the ideal level of operating reserves as the equivalent of six months of average operating cost, within a range of three months above or below this level. As at 31 March 2022 the requisite level of reserves on this basis was £394k.

Actual operating reserves as at 31 March 2022 amounted to £753k (2021: £785k).

Council have agreed that, with real or perceived changes in future income opportunities, a risk-based reserves model may be a more appropriate method in safeguarding future Society �nancial sustainability, and a policy to this e�ect will be developed over the forthcoming �nancial year.

Going concern

The trustees have assessed whether the use of the going concern basis is appropriate and have

considered possible events or conditions that might cause signi�cant doubt on the ability of the charity to continue as a going concern. In particular, the trustees have considered the Society’s forecast and projections having taken account of current and anticipated �nancial performance, together with its current its reserves position, cash liquidity, and the ability to draw down on readily realisable investments as required in light ofthe impacts experienced andexpected ofglobal events and the downturn in the global economy.

Taking these factors into account the trustees are satis�ed the Society has adequate resources to continue in operation for at least 12 months from the approval of the �nancial statements. The Society therefore continues to adopt the going concern basis in preparing its �nancial statements.

The Society will continue to monitor and assess �nancialriskthroughits O�cersandCouncil,recording and mitigating any uncertainties in accordance with its risk policy.

Investment policy and performance

The trustees operate an investment strategy of balanced risk, seeking to provide an income stream supporting Society activities and operations, while protecting income and capital values, at least in real terms, through longer-term growth.

Following an investment manager review in 2018, the Society holds its investment portfolio with Sarasin and Partners LLP.

Investments are diversi�ed between short-, mediumand long-term funds, aligned with the Society’s strategic aims, integrating medium-term liquidity requirements within the operating reserves policy, whilemaximisingreturnsandgrowththroughbalanced risk in longer-term funds. The funds are benchmarked against relevant composite indices.

The equity holdings within the Sarasin and Partners LLP funds are identi�able. Ethical restrictions applied include no investment in tobacco manufacturers, and the avoidance of investment in companies that generate signi�cant revenue from alcohol manufacture, armaments, gambling or pornography.

14

For the year ended 31 March 2022

Pensions

Future viability considerations

The Society provides a de�ned-contribution workplace pension for the bene�t of sta�through its provider, the People’s Pension. The Society matches employee contributions to a maximum of 7%.

The Society is currently developing income generation and diversi�cation strategies, as underpinned by the Future Sustainability Fund within Designated Funds, to enable both sustainability and growth in future activities.

Our ro ress 2021–2022 p g

Membership

Communications

During the period 1 April 2021 to 31 March 2022, the HIS membership grew by 17%, with a total of 1,389 members at the end of March 2022 (2021: 1,186).

As of 31 March 2022, the membership comprised 723 Full members (2021: 620), 90 Associate members (2021: 85), 480 Trainee members (2021: 412), 42 Emeritus members (2021: 39), 51 Associate Trainee members (2021: 27) and three Honorary members.

The largest increases in membership numbers were in the Full and Trainee membership categories. The increase in Trainee membership numbers was a result of increased numbers of trainees registering to access the online Trainee Education Days.

Pre-pandemic, the average attendance at Trainee Education Days was between 90 and 120 trainees. On moving to an online delivery format, attendee numbers exceeded 300 at some events.

The reintroduction of the Don’t Panic! conference and DIPC days (online) also saw new members joining to take advantage of member registration rates.

The conversion ofTrainee toFull membership remained steadyat 30% for the period April 2021 to March 2022. During this period HIS launched a new consultants’ working group whose remit, amongst other things, is to review the process for converting from a Trainee to Full member.

During the year, the Society continued to engage with membersandkeystakeholdersviatargetednewsemails and the his.org.uk website. Twitter continued to be a keytool for building engagement and brand awareness with members and the wider IPC community, and for promoting a reputation for excellence, relevance and expertise.

Email

The average monthly open rate of the monthly newsletters continues to be very high as compared with industry standard in the sector (~31%): 41% for the members’ newsletter and 46% for the trainee newsletter.

Twitter

The @HIS_infection Twitter following grew by over 25% to 7,157 to the end of March 2022 (2021: 5,715). During this period tweets made an average of 37,000 impressions per month; although this was lower than in 2020/2021, the HIS Twitter channel has increased tra�c to the his.org.uk website, with tweets receiving an average of 1,000 link clicks a month.

The JHI Twitter account has continued to grow in popularity, with 3,623 followers – an increase of 671 from last year. The journals’ Twitter accounts highlight key papers, issue calls for papers, present threads of related papers, notify followers of new issues of the journals, and engage with readers and authors.

15

Healthcare hfecUonSocletyAnnu•l R¢port Blog From the HIS staff team, convenors and speakers to The HIS blog provides an informative. but informal, transition thecourse loan online formal, buta Full Four- Forum for opinion, interviews and obseNations related day course was successfully delivered online, including to IPC. The blog continues to be a popular read for HIS pre-recorded speaker presentation5, a live Q&A and members and the wider IPC community. live interactive prattical sessions each day. Two Further courses (expanded to five days) took place in December 2021 and February 2022, with 50 delegates attending each course. Between April 2021 and March 2022, the blog played a role in highlighting IPC issues in lower income settings: Felicity Fitzgerald wrote on the success of the app Ne0T￿e (recipient of a HIS Small Research Grant in a previous yearl. which aims Lo improve neonatal care in low-resource Settings, and the IPIP article collection on 'the local. the contextual and the pragmatic, was launched with a blog by Editor in Chief Gemma Winzor. Following the initial success of the online Trainee Education Days in 2020. the programme continued via Zoom during 2021-22, with three further days: Reducing Harm to Patients and Improving Quality C¢F Care., Surgical Site Infection Iluly 2021. 183 delegates)., Public Health Aspects OF IPC, Inclijding Implications of Tfavel Ioctober 2021. 200 delegates}; and Environmental Aspects OF IPC.. Risks and Solutions (February 2022, 267 delegates}. HIS journal articles have been usefully expanded and built upon in blog p05t5 which seek to dive deeper into HIS publications. 'Should we be using Chlorhexidine dressings with external ventricular drains?. by Mueez Waqarand Abdurrahman Islim began asan article in the IHI, and'Bot the difference., is hand hygiene adherence betterwith orwithout a robot?, by Hemendra Worlikar, james O'connell and Derek O'KeeFfe was based on an article first published in IPIP. The first in-person OUtb￿ak$ Training Courses since CQVID-19 ￿$trICt10n5 were enForced took place at Montaqu House on 16 September 2021. 18 November 2021 and 31 March 2022. The courses were organised with extensive COVID prevention measu￿5 in place 3nd small groups OF between seven and ten delegates attending. Events and education The first online HISIUKHSA Foundation Course in Ipc The Engineering Aspects of Infection Control Course took place at the end OF April 2021. with 53 delegates also returned in a face-to-face format at Eastwood attending. A significant amount of work was reqUI￿d Parkduring October2021.The HIS team worked closely Belovr. Featured HIS blog article. 17 IBnuary 2022 171ANUARY2021 Have lelephone consulialions improved privacy For our paLients? The COVID-19 panoemit has traftsformed Iheways In whichwe cofflfflunlcaie and Interaci In ourworking Ilves. Drmlchael Kamdar explore5 the Impaci on paileni experience an Infecllous Diseases deparlffleni. More 16

Foriheyearended31 March2021 with Eastwood Park Training Centre to ensure that event, 'Influencing Others and Changing Behaviours,, appropriate COVID-secure measures were in place and was less well attended152 delegates) but a150 received a smaller group of I I delegates attended (as opposed positive Feedback to the usual 161. Due to the ongoing pandemic. the POPLblar Don't ThehugelysuccessFulaudience-ledwebinarscontinued Panicl conference was hosted online For the first time. through 2021122.. eight further webinars were hosted. Over 130 delegates attended to hear speakers on Th￿e webinars in the COVID-19 Challenges and range of topics including pneumonia, UTIS and high Solutions series took place between May and july consequence infectious diseases. 2021. These We￿ attended live by over 500 people. In September the first of the InFettion P￿ventIon Challenges and Solution5 webinar series launched on the topic of waterborne inFections, followed by a second on surgical site infections. During 2021, HIS supported the British Infection Association IBIAI in the planning and promotion of FIS 2021 which look place asa hybrid event on 5 November at Manchester Central, UK and 8-9 Novemberonline, To support the publication of the updated HIS and IPS guidelines on Methicillin-resistanl Stophylococcus Ou￿US IMRSAI and the HIS guidance on rinse water For endoscope washer-disinFeclors, the Spotlight on Guidelines webinar series was launched. In these webinars, members OF the guideline Working Parties anSWe￿d questions submitted by the audience. These were well received, and similarwebinars are planned For HIS quideline publications in the future. Over the vear. Hlswebinarswereattended live byover1,500 attendees. The Lowbury Lecture, entitled 'Tales of the unexpected in antibiotic resistance, was delivered by Professor Marc Bonten IUMC Utrecht) on 5 November. HIS organised a session on hospital-onset COVID inftction online on 8 November. In collaboration with the Microbiologysociety IMS), HIS began planning asecond Bridging theClinical-Research Gap workshop. This workshop, aimed at bringing together academic and clinical microbiologists, was scheduled to take place in February 2022 but was postponed to September 2022 due to the pandemic. The first online DIPC Development Day, 'Investino in the Future: Quality Improvement and Education,. took The one-day Introduction to Guideline Development place on 21 June.The event received excellent Feedback Course launched in 2020 was Tepeated in May 2021, and was attended by 90 delegates. The second online 5eptember2021 andJanuary2022. The course retained Belo¥r. Marc Bonten deliveriny the 2021 FIS Lowbury Lecture UMC Utvttht Tales of the unexpected in antibiotic resistance IIS 2021 Fodttit5Dnof InforthnSxdKCoDknn Ft.Oay5 Now￿tr l Mafflcht5ter Cthtiil, UK ltsnthly8.TW￿1V9 Nrrtffjber l Onhn Marc Bontern UMC ut￿Cht BIAI

Healthcare hfecUonSocletyAnnu•l R¢port an online format. with up to 15 delegates attending H IS journals each event. The range OF participants was broadened to include non-HIS members. Journal of Hospital Infvction TheJHI publishes high-quality, peer-reviewed research and commentary relating to IPC in healthcare settings. Itis a monthly publication and continues lo be a leadino jOL*rnal in its field. The Course programme mvered the phases of guideline development, the design and conduct of systematic evidence reviews as part oFguideline development. and the Formulation of recommendations taking account of available evidence. The past year saw a return to 'normality' on the JHI: From April 2021 to March 2022, theJHI received a total C¢F 1,236 submissions. While this was higher than the pre-pandemic average OF 990. it was far lower than the pandemic heights OF 2,570 in 2020. 207 articles were accepted for publication. The average time from submission to first decision was 9.5 days, and the time from submission to acceptance for articles going through peer reviewwas 9.5 weeks on average. Educational resources To further promote the publication of the joint HIS and IPS guidelines on MRSA , four short IPC in 5 reSoU￿S We￿ produced. These covered MRSA surveillance, the management oFpositive individuals and $c￿enIng, External events The 2020 JHI impact factor (IF) was released in June 2021, The IHI experienced a 20% increase to 3.926, moving up one place in the Clarivate infectious diseases category (now 361921, but dropping to 561203 in the public, environmental and occupational health category. 3.926 is the highest IFJHI has received.. Due fo the COVID-19 pandemic, external events in which HIS would normally participate were Cancelled or postponed. As such the Societywas unable to exhibit at any external events during the period. IHI articles were downloaded 737.092 times belween Below.. One oFthe IPC in 5 resources • Healthcare InFeciion Soc Infectlcn Pr￿en Sxiety Joint Healthcare Infertion 50¢iety IHIS) and Infection Prevention Society IIPSI guidelines for the prevention and Control of meti¢Trllin-resi5tant 5tophyloco¢¢us uureus IMRSAI in healthcare facilities Overview PioFessorPeterWilson g * ¢t IPR NEKr? 18

For the year ended 31 March 2022

April 2021 and March 2022. The most-downloaded articles published in this period were de Hatanaka et al.’s ‘Chlorine dioxide is a more potent antiviral agent against SARS-CoV-2 than sodium hypochlorite’ (12,511 downloads) and Man et al.’s ‘Airborne SARSCoV-2 in home and hospitalenvironments investigated with a high-powered air sampler’ (7,655 downloads).

The journal published several special sections: in May 2021, the annual Global Hand Hygiene issue featured the World Health Organisation’s announcement of the ‘Seconds save lives – clean your hands’ campaign, and a piece from the JHI editors entitled ‘Hand hygiene: a COVID bene�ciary?’ accompanied by relevant research and review articles. The May 2021 edition also featured a special section on water systems, headed by an editorial piece from Mike Weinbren and Teresa Inkster on ‘The hospitalbuilt environment: bio�lm, biodiversity and bias’.

The November 2021 special section covered World Antibiotic Awareness Week, with an editorial from the JHI editors and a selection of articles, reports and reviews on the subject. In January 2022 a special section on COVID-19 featured an editorial by the JHI

andIPIPeditors on‘LessonslearnedfromtheCOVID-19 pandemic through the JHI and IPIP’.

Other papers of note included the 2020 Lowbury Lecturer’s accompanying article, ‘Linking infection control to clinical management of infections to overcome antimicrobial resistance’ by Evelina Tacconelli, and the joint HIS and IPS ‘Guidelines for the prevention and control of MRSA in healthcare facilities’ as a supplement to the JHI in December 2021. This was accompanied by an MRSA special section in the main December edition, with an editorial by the JHI editors entitled ‘New MRSA guidelines: New evidence for dealing with an old problem’.

The Editorial Team of the JHI consists of Editor in Chief Jim Gray and Editors Nik Mahida and Martyn Wilkinson. In 2021, the International Editorial Board (IEB) of the journal was updated. New members were invited, while members who had been less active stepped down. There are now 103 members of the IEB from 28 di�erent countries.

Other projects in 2021–2022 included an update of the Instructions for Authors, and amendments to the

Below: Journal impact factor trend 2016–2020

19

Healthcare hfecUonSocletyAnnu•l R¢port article typesoFfered on thejournal: opinion pieces were consolidated intoeithereditorialsof commentaries.and the instructions For original research and short reports were merged to allow for varied lengths of research article to be submitted. We additionally removed case reports and outbreak reports, instead urging authors to submit thesè to IPIP fortonsideration. theirfunding. localion ortheavailabilityoFinstitutional access. The journal was indexed in Pubmed in July 2021. achieving a key goal in its development. Indexation caused an immediate spike in submissions as the journal became more visible to researchers. Thejournal was indexed in Scopus in early 2022. and a submission Infection Prevention in Practice has been made to Clarivate for indexation - wlth the IPIP launched in March 2019 as the Society's first gold goal off￿ce{vIng an impact factor For the joumal. open accessjournal. It is Iow-c05t and online-only, and prowdes a freely-available resource that is accessible In September 2021. the journal published a special to all those working in the field OF IPC, Ir￿speCtive OF section entitled 'FIS Poster Prize.. learning from pragmatic local ￿SearCh.. which Featured three reportswritten bythe inaugural IPIP Poster Prize winners, fmm th@ FIS/HIS IntÈmational Conference 2020 IF151HIS 20201. These were accompanied by an editorial piece on 'Leaming from pragmatic local research,. Healthcare InFeclion Society THEIOURNAL OF Submit your research. reviews and views to the Journalof Hospitollnfvction Hospital InFection second special section was Pltblished in the December 2021 edition. Featuring work on the hospital built environment, The third in IPIP'S unique Debate5 in IPC article series was also published in the December issue. These articles provide two side5 of an interesting debate in IPC. with two different articles arguing 'for' and 'against' motion. In 'Subspecialisation within infection p￿ventIOn and control,. Mike Weinbren and Te￿sa Inkster argued in Favour of greater s￿bSpecIall5at10n in training, and Peter Wilson and Leila Hall argued against. Thejournol ofHosPltdl ectionUHII ts an editorially Independent scientific publlcatlon oFlhe Healthcaie InFeclion 5ocieLy. Alongside special issues. IPIP has pioneered arlicle collections in the last year. In these web-based issues, previously-publi5hed articles a￿ gathered thematically and promoted. The three article collections launched in the last year were 'lnfection prevention and 2022 3.926 ELSLI'IER 20

For the year ended 31 March 2022

control in low-resource settings: the need for the local, the contextual and the pragmatic’, which highlighted work from lower- and middle-income countries and featured an editorial piece; ‘The hospital built environment’, which collected work on water systems and ventilation, and o�ered an outbreak report as an example for readers; and ‘An Infection Prevention in Practice review round-up’, which gathered important review articles published by the journal.

The editors of the JHI ‘cascade’ manuscripts which are deemed to be of a good quality, but are out of scope for the JHI, to IPIP by o�ering the author the option to transfer.

In 2021-2022, 73 manuscripts were transferred from the JHI to IPIP, and transferred manuscripts accounted foraround 50% ofpublished output on IPIP. The journal received 161 submissions overall between April 2021 and March 2022. In the same period, 63 articles were accepted for publication in the journal.

Downloads for IPIP were also strong in 2021-2022: total downloads for the period were 136,955.

Top-downloaded articles included ‘Evidence review of physical distancing and partition screens to reduce healthcare acquired SARS-CoV-2’ by Rooney et al. (2,338 downloads), ‘Nosocomial or not? A combined epidemiological and genomic investigation to understand hospital-acquired COVID-19 infection on an elderly care ward’ by Wenlock et al. (1,535 downloads) and ‘Association of environmental surface contamination with hand hygiene and infections in nursing homes: a prospective cohort study’ by Teesing et al. (1,392 downloads).

The Editorial Team of IPIP comprise Editor in Chief Gemma Winzor, who has worked as an on IPIP since launch, Pauline Jumaa, who joined in January 2021 and Jim Gray, who advises on the journal.

The core Editorial Team are supported by the journal’s independent IEB, composed of 17 members from ten di�erent countries and possessing a wide range of expertise.

Katie Prescott, a Graham Ayli�e Fellow on the HIS journals, paused her Fellowship due to the COVID-19

IPIP is low-cost and online-only, and provides a freely-available resource that is accessible to all those working

in the �eld of IPC, irrespective of their funding, location or the availability of institutional access.

pandemic and resumed her work with the journals in March 2021. She completed her �nal few months with the journal in August 2021, contributing greatly by providing peer review, handling articles in an editorial capacity and writing editorial commentaries, and commissioning content. Katie was invited to become a member of the IPIP IEB.

The science of IPC

The Society actively promotes evidence-based clinical best practice and harnesses the expertise of members to produce expert-led clinical guidelines and guidance. The Society seeks to improve the available evidence base by supporting research through its funding portfolio. Guideline production and the funding portfolio are under the purview of the Guidelines Committee and the Research Committee, respectively.

Clinical guidelines and guidance

The Society uses National Institute for Health and Care Excellence-accredited (NICE-accredited) methodology to produce clinical guidelines, and tools such as network method analysis to produce evidence-based and expert recommendations for best practice.

NICE accreditation enables health and social care professionals to identify the most trusted sources of guidance. NICE-accredited guidelines are developed

21

Healthcare Infection Society Annual Report

using critically-evaluated, high-quality processes to a high standard. The accreditation is granted to organisations that consistently demonstrate the implementation of rigorous processes for guideline development.

In 2020, due to the COVD-19 pandemic, Working Party activities were paused and rapid guidance was produced to support IPC practitioners through the pandemic. Following this period, the trustees decided to refocus resources and sta�ng in order to complete outputs from the Working Parties.

Working Parties active between April 2021–March 2022

Guidelines published

Since April 2021, the following guidelines have been published:

The following guidance was also submitted to BMC Infectious Diseases in early 2022 and published in May 2022:

Additionally, Working Parties have supported the Society in the development of additional resources such as patient lea�ets, one-page summaries and IPC in 5 overviews. The Spotlight on Guidelines webinar series launched and has hosted four webinars since mid-2021.

Grants and bursaries

Career development and research is supported by the Societythrough a portfolio of grants, bursaries, smaller awards (for example, travel bursaries) and larger awards such as the Major Research Grant. This funding supports career-development opportunities and the development of knowledge in infection prevention science that will ultimately lead to better patient outcomes.

The Society became a member of the AMRC in 2021, which con�rms high standards and transparency in its grant awarding and peer review processes.

22

For the year ended 31 March 2022

Graham Ayli�e Fellowship

Razan Saman of Leeds Teaching Hospitals NHS Trust started her Graham Ayli�e Fellowship year in August 2021. Razan is looking at strategies to prevent the transmission of extended spectrum beta-lactamase Enterobacterales. This process includes completing systematic reviews and developing a core outcome set to be used in future clinical trials. Razan is also working with patients and stakeholders in the development of di�erent trial designs.

The Research Committee have reviewed the eligibility criteria and application process for the Graham Ayli�e Fellowship after gaining feedback from Society Committees and members. The application process is now a two-stage process that includes mentoring during the preparation of the full application, with an opportunity to become involved in di�erent Society activities. The Fellowship is now open to those on a Higher Specialist Scienti�c Training pathway in microbiology.

Major Research Grant

The Major Research Grant of £99,000 was awarded to Toney Thomas Poovelikunnel in April 2021 for a study entitled ‘The safety and tolerability evaluation of a novel mupirocin formulation on patients colonisedwith oro-nasal methicillin resistant Staphylococcus aureus (MRSA) in a randomised phase II trial.’

The project teamworked to achieveregulatoryapproval with Health Products Regulatory Authority in Ireland. However, the product manufacturer withdrew from the project in early 2022. While e�orts to secure an alternative manufacturer are being made the grant has been put in abeyance.

Small Research Grants

One Small Research Grant of £10,000 was awarded in December 2021 to Harry Dean of St Marks Hospital and Academic Institute for an investigation entitled ‘Prospective bacteriology of surgical site infection following surgery for intestinal failure’.

Travel grants

The Society awards travel grants to enable members to present at meetings of educational bene�t. Meeting organisers started to o�er a hybrid, virtual and in-

person format in late 2021. In the year to March 2022, three travel grants of £750 were awarded for in-person attendance at the 32nd ESCMID which was held in Portugal in April 2022.

Rescinding of grants

The Society introduced new terms and conditions in 2018. Since this time, the progress and communication forallfundedgrantsandfellowshipshasbeenmonitored and reported to trustees at each Council meeting.

In early 2021, a working group of trustees was formed to assess if the progress of three awarded grants was su�cient to justify continued funding. Following a detailed review the trustees decided to withdraw support for two Small Research Grants that had been awarded in 2017 and 2018.

Consultations and in�uencing

On21September2021TheHouseofCommonsScience and Technology Committee and Health and Social Care Committee published a report entitled Coronavirus: lessons learned to date. The report examined the initial UK response to the COVID pandemic. HIS members contributed to the expert panel.

Public Health England (PHE) convened an expert RespiratoryEvidencePanelinFebruary2021tocritically assess the evidence behind SARS-CoV-2 transmission to inform their guidance and recommendations. Nominated individuals from UK-wide professional infection societies (including HIS) contributed to an expert panel statement published in October 2021 on the role of face coverings in mitigating COVID-19 transmission.

Guidance on Good infection prevention practice: using ultrasound gel was published by UKHSA on 10 November 2021 and updated 26 May 2022. The guidance was developed following a review of published literature, and was informed through outbreak investigations, and through consultation with key medical and subjectmatterexperts and users ofultrasound gelwithin the UK.

Recommendations were discussed in workshops and agreed upon in consultation with a core working group of stakeholders that included representatives from

23

Healthcare Infection Society Annual Report

HIS. The Society was represented on the NHS England/ Improvement (NHSE/I) working group for the National Standards of Healthcare Cleanliness, which produced the linked document in August 2021. Additionally, representatives of the Society were part of the British Standards Institution (BSI) working groups on water and disinfection.

Montagu House includes a library the HIS membership can make use of, and meeting rooms which can accommodate educational workshops and meetings of HIS Committees and Working Parties.

Our headquarters

Montagu House became the o�cial HIS headquarters in September 2020.

The building was constructed during 2019 and 2020 on the site of an old dairy located in Wake�eld Street, Bloomsbury, London, WC1N 1PG. The HIS sta�team occupy the lower ground �oor, which includes a library the HIS membership can make use of, and meeting roomswhichcanaccommodateeducationalworkshops and meetings of HIS Committees and Working Parties. The upper two �oors are con�gured for the purposes of income generation.

Below: HIS headquarters, Montagu House

24

For the year ended 31 March 2022

Our lans for 2022–2023 p

The 2020-2025 strategy is underpinned by three key pillars of activity and engagement which support HIS members to deliver excellent clinical practice for the bene�t of the public:

1. Programme of activities

HIS will fund a diverse range of research and produce expert guidance on the control and management of HCAIs.

HIS will deliver an expert-led, high-quality programme of training and events.

HIS will provide accessible platforms for the dissemination of high-quality, peer-reviewed research.

2. People

HIS activities and publications will support the professional development of Society members and the wider IPC community at all career stages and levels.

HIS will encourage members to become involved with the Society to help it realise the vision of a world in which HCAIs have been reduced to the lowest possible level.

HIS will support and develop sta�and volunteers.

3. Perception

HIS will ensure the Society’s brand, website and key messages communicate that HIS is expert-led and the authority on the delivery of activities and publications that drive best practice.

Although the uncertainties surrounding the COVID-19 outbreakandpressuresonHISvolunteersandmembers will continue to impact the original activities and plans to achieve set strategic objectives during 20212022, the Society has adapted its planned programme of activities to consider social restrictions on mass gatherings andtravel, and also on the availabilityofHIS members to participate.

As reported last year, the COVID-19 outbreak created an opportunity for the Society to review how key activities are delivered, and has led to a transition from the delivery of face-to-face events to online events.

Membership engagement

During 2022-2023, HIS will continue to grow and support the membership network, paying particular attention to the support o�ered to early-career consultants as the new consultants’ working group becomes active.

Equality, diversity and inclusion

The diversity of the HIS membership and Committees is currently under review, and is discussed further on page 30 of this report.

Training and education

From May 2022, the Society will run face-to-face conferences again. The Spring Meeting on ‘Futureproo�ng healthcare ventilation’ will take place at BMA House in London the day after the Society’s postponed 40th anniversary celebration event.

The Spring Meeting will be followed in June by the Don’t Panic! conference in Manchester and the DIPC Development Day, Taking Surveillance Forwards: Making the Most ofYourData. Thiswill be the�rst fullyhybrid event o�ering delegates the opportunity to join either in person in London or online.

In September, HIS will host FIS/HIS 2022 as a two-day face-to-face conference in London followed by a onedayvirtual event, with all content available on demand post-event. All delegates who register to attend across three days will, for the �rst time in the history of FIS/ HIS, be able to access the content from all four parallel sessions for each day after the event.

Due to the success of the online format, the Trainee Education Days will be delivered online during 2022, with theOutbreaks Training Courses delivered face-toface at Montagu House three or four times each year.

The Engineering Aspects of Infection Control Course will also continue in a face-to-face format in June and September 2022 at Eastwood Park Training Centre in Gloucestershire.

25

Healthcare hfecUonSocletyAnnu•l R¢port The Introduction to Guideline Development Course has Social media proved very popular, and will therefore be oFfered at regularintervals throughout 2022-2023. HIS social media platforms will continue to be a source Df support For members and the wider IPC community, and will continue to communicate updates to inFection guidance clearly and quickly. The team behind this course are building a portfolio of online guidelines and evidence courses designed to introdLtce participants to processes and methods relevant to clinical guideline development. This will include a one-day Health Economic Evaluation Course (April 20221 and a one-day Understanding Network Meta-Analysis Course (autumn 2022}. Podcast: Infection Prevention in Conversation The Spotlight on Guidelines webinar series. which compliments the publication of HIS clinical guidelines, will continue as guidelines are published. The InFection Prevention Challenges and solution5webinarsefies will be expanded to collaborate with other organisations and the wider IPC community, The journals team a￿ in the early stages offplanning a podcast dedicated to di5CUS5ing the latest IPC research. The podcast is scheduled to launch in Q2 2022. Ourjournals Journal of Hospital Infrction The postponed 8ridging the Clinical-Research Gap The JHI Faces a big change in the coming year. the workshop will be run in collaboration with the MS in current Editor in Chief Jim Gray's term comes to an September 2022. Due to the interactive nature OF the end in september 2022. The process OF seeking a new event. the workshop will take place face-to-face in Editor in ChieF has Commenced with adverts inviting Birmingham. applitations, with a deadline OF March 2022, Once applicalions are received HIS Councilwill select thenext Editor in ChieF and a handover period will commence from the beginning oFAugust 2022. During 2022, a new Learning Management Platform will be implemented and launched with a new-Format HIS/UKHSA Foundation Course in IPC in the Spring of 2023. Following a busy couple ofyears on the journal during the COVID-19 pandemic, 2022-2023 will be a good Dpportunity for the team to reset and reconsider the aims. scope and criteria for acceptance for the journal. A new system to triage papers will be introduced, and the publication is working with Elsevier to study areas OF high-citation to ensu￿ wmmissioning plans are impactful. Infection Prevention in Practice Following the success of IPIP'S first Iwo years OF publication, the Editorial Team, led by Editor in ChieF Gemma Winzor. intends to create more themed article collections highlighting the bestworkpublished in IPIP, with the goal OF attracting more submissions. The IEB Dn IPIP is due to be updated in 2022-2023, alongside n update to the Guide forAuthors. NFECTI PREYE ION IN CONVERSATION The journal's application to be indexed in Clarivate s Emerging Citation Index has been submitted, a year 26

For the year ended 31 March 2022

soonerthanplanned.Indexation in this database opens the journal up to being indexed in Clarivate’s main Web of Science database, which assigns impact factors. The team anticipates a positive response shortly.

The journals team will continue to increase the international pro�le of the JHI and IPIP, and will work with Elsevier to best position the journals’ business against changes to the wider publishing landscape, and with the Society Publisher’s Coalition to defend the interests of Society journals as debates around changing business and funding models in publishing develop.

Income diversi�cation

Montagu House was purchased with the capacity to generate income through the letting of commercial space to other organisations.

While this was delayed due to the impact of the pandemic, tenants are now in residence and this new income stream, coupled with the diversi�cation of the investment portfolio and the development of new online educational courses, will help to ensure the long-term �nancial sustainability of the Society.

Guideline production

Prior to 2021 the Society implemented a rolling update and review programme for all previously-published guidance and guidelines. An emphasis on clinical priority has been added to this system.

The Society will continue to invite the community to propose guideline topics. The website was updated during 2022 to explain the method of guideline production to facilitate this process. The guidelines sta�team will continue to produce guidelines within newly-de�ned timeframes and work with members of each Working Party at key points in the guideline development process to consider the link between the evidence and clinical recommendations.

The Society is also looking towards developing pragmatic guidelines and tools for implementation that capture the patient voice.

Research and grant funding

The Research Committee continually evaluates both the funding portfolio and application processes to ensure that HIS grants and bursaries support the strategic aims of the Society and are supported by the current research strategy.

The Research Committee will be examining how the Society should measure impact and support research that promotes good clinical practice.

27

Healthcare Infection Society Annual Report

Our governance

Governance structure and management

The nature of our governing document and how the charity is constituted

The Society’s governing document is the current Constitution which incorporates elements of the Society’s previous documents into the current requirements of the Charity Commission for a CIO. In recent years, the Constitution has been amended on a number of occasions in line with changes to the Society’s membership and governance structure.

In November 2021 the Constitution was amended to specify that the election of trustees should follow an open recruitment process where there is a published call for nominations from the membership. Following this open call, trustees then make the �nal recommendations in terms of the selection of candidates as they have a full knowledge of the current skills gaps on Council.

Organisational structure and decision-making process

The business of the Society is conducted by Council, which meetsquarterly.Councildeterminesthe strategy ofthe Societyandreviews progress against its strategic aims and objectives. Council reports to the members via the AGM, by notices on the his.org.uk website, by post and by email.

The O�cers, the Chief Executive O�cer (CEO), the Chairs of the Standing Committees and the Editor in Chief meet in person or by teleconference as and when required to discuss key issues, and their proposals and recommendations are taken to Council for discussion and formal decision making.

The Society’s AGM was held as a hybrid event on 5 November 2021 during FIS, and minutes are available on the Society’s website.

Council and Committees

As a charity, HIS is governed by Council who may coopt members and appoint Committees. HIS Council are members of the Society (with the exception of the

Lay Trustee) who are either appointed by Council or elected by the membership for a de�ned term. With the exception of the Lay Trustee, only Full and Trainee members of the Society are eligible to be trustees.

Council

There are a maximum of 13 Trustees of the Societywho are all members of Council.

O�cers

Ordinary Council members

Lay member

Co-opted members

28

For the year ended 31 March 2022

The Chairs of Committees are appointed for three years in the �rst instance but trustees can extend this term by a further two years. Neither the Chairs nor Co-opted members are trustees by virtue of their position on Council.

Committees

HIS Committees are formed through the election of representative members who are healthcare professionals who have volunteered to contribute to guiding and driving Society strategies and activities. They are largely consultant microbiologists and virologists, trainees enrolled on a specialty training programme, infectioncontrol nurses, sta�from UKHSA and healthcare scientists.

Policies and procedures for the induction and training of trustees

Trustees participate in an annual trustee development and training session and are provided with the Trustee Induction Handbook which includes the Society’s Constitution, details of Society policies and procedures and information on trusteeship from the Charity Commission. Trustees also have access to online

training material provided by the NCVO. A register of interests of trustees is maintained, and declarations of interests are made at all Council and Committee meetings. The trustee role description was reviewed during the year.

Governance reviews

Following a review of the Society’s Constitution and governance structure by the NCVO in March 2019, a number of recommendations were made, including a reduction in the number of Co-opted members who serve on Council and the management of con�icts of interest. Trustees considered recommendations made and aligned these to the delivery of the Society’s new strategy and sta�team, and the new Committee structure was implemented following the 2019 Annual General Meeting (AGM).

Key changes:

Committee Chairs are trustees (where practical).

----- Start of picture text -----
HIS
Council
Equality, New
Executive Professional
diversityand Trainee Research Guidelines consultants'
Editorial Development
inclusion focus Committee Committee Committee working
Board Committee
group group
HIS
sta�team
----- End of picture text -----

29

Healthcare hfecUonSocletyAnnu•l R¢port All Committees listed beloware new(with the exception of the Executive Editorial Board and the Trainee Committee, whose composition changed): implementation began immediatelywith the collection DFEDI data From the HIS membership. Our five EDI objectives ProFessional Development CommiLtee. • Research Committee. Objective 1 Guidelines Committee. Trainee Committee. • ExÈtutivÈ Editorial B03rd. The new HIS Committees mel Forthe first time in 2020. and the Terms of Reference for all Committees were revi@wÈd and amÈndÈd ahoad oFtho 2021 AGM which marked two years since iheirinception. ua ity, diversi ' inclusio The Governance Code The Governance Code is a practical tool intended to help charities and theirtrusteesdevelop high standards OF governance. The trustees of the Society have used the principles included in the Governance Code to review ihe perForman¢e OF HIS Council on an annual basis since 2017. In addition. a review OF trustee skills. contributions and training requi￿rnents is conducted annually, alongside appfaisals by the Chair. Understand diversity within the IPC community and review key diversity inFormation in relation to our volunteers (Council, Committees, Working Parties, Editors), members and staff acr055 all HIS activities. This includes membership recruitment and relention. event speakers and atLendees. granL applicanLs and journal editors. Dbjective 2 To enact our responsibility to embed an understanding and promotion of EDI amongst all volunteers and staff. Objective 3 Ensure there is representation of key communities throughout volunteer and stafF Leams and throughout all of our activities. The Governante CodÈwas reFreshed towards thÈ end OF 2020, and the Society has understood and responded to the key changes to Principle 6: Equality, Oiversityand Inclusion IEDII. In 2021 HIS Council and staff took part in an EDI workshop delivered by the Equality Academy. Equality, diversity and inclusion: developing a strategy Objertive 4 Ensure communications reflect our commitment to EDI. In March 2021 trusteesa9reed to furtherreviewhowHIS can ensure itwelcomes everypotentialSocietymember working in IPC in healthcare settings, and further to ensure that every member has the opportunity to contribute to the goals of the Society as a trustee or Committee member. Objective 5 Ensure EDI is a key part of strategic decisions and led by Council. To this end, a new Committee, the EDI Focus Group IEDIFGI, was Formed in order to develop an EDI strategy For the Society. In November 2021, trustees approved five EDI strategicobjectives proposed by the EDIFG, and 30

Foriheyearended31 March2021 Timeline: EDI initiatives 19805: Travel grants The Society awarded travel grants to support members in an early-careeror trainee post to present their research at a scientific conference or meeting. HIS offers travel grants and bursaries to support delegates who may have difficulty obtaining funding to attend FIS and H15 International Conferences. and also offers travel grants to support members presenting at non-HIS conferences. 2017 Creation of the Council Lay trustee role. 2018-2019 Membership categofies and criteria were broadened to be open to all those currently working in IPC orwith an interest in HCAI. 2019 Membership fees were reduced For members in low- and middle-income countries. 2019 Launch oFa gold open access journal, IPIP, with low article processing charges IAPCS) to increase accessibility For clinicians who do not receive research Funding. In addition, members From low- and middle-income countries automatically receive an APCwaiver. 2019 Composition oFall HIS Committees was reviewed to ensure representation From acfOSS the membership. 2020 Mike Emmerson International Fellowship launched and open to healthcare professionals From low-income countries to undertake the clinical observership at a hospital or community setting in the UK or republic of Ireland. 2020 New membership category of Associate Trainee member launched specifically For undergraduate medical students and others in pre-specialty training. 2021 Manjula Meda appointed as Honorary Membership Secretary and Chairof a new EDI Focus Group, 2021 HIS Council approve EDI strategic objectives proposed by EDI Focus Group. 2021 EDI data begins to be collected From the HIS membership. 2022 EDI standing item on all agendas, 2022 EDI blog published. 31

Healthcare Infection Society Annual Report

Organisational structure and decision-making process

The business of the Society is conducted by Council, which meetsquarterly.Councildeterminesthe strategy ofthe Societyandreviews progress against its strategic aims and objectives. Council reports to the members via the AGM, by notices on the his.org.uk website, by post and by email.

The O�cers, the Chief Executive O�cer (CEO), the Chairs of the Standing Committees and the Editor in Chief meet in person or by teleconference as and when required to discuss key issues, and their proposals and recommendations are taken to Council for discussion and formal decision making. The Society’s AGM was held as a hybrid event on 5 November 2021 during FIS, and minutes are available on the Society’s website.

Land and property

The Society retains title to all land held by the Society, which,atthe dateofthisreport, consists ofthefreehold land and property at Montagu House, 7E Wake�eld Street, London, WC1N 1PG.

External collaborations

HIS is represented on numerous national and international committees, working groups and other forums. The following is a list of these groups and the current HIS members with involvement up to 31 March 2022. International Federation of Infection Control: Board, Elisabeth Ridgway

Below: Peter Ho�man and delegates at the Engineering Aspects of Infection Control course.

32

Foriheyearended31 March2021 and Antiseptics, Karren Staniforth BSI Waler Safety Group. Mike Weinbren Academy of Medical Royal Colleges Clinical Reference Group, Lucia Pareja-cebrian Trainee Association of ESCMID, lenniferwalsh NH5E & NHSI collaborative working group on personal protective equipmenL, Manjula Meda National Quality Assurance Advisory Panel For Medical Microbiology,lames Price NHSE/I IPC Education Framework. Eimear Brannigan NHSE/I National InFection Prevention and Control Manual Sleering Group.James Price University of West London Project Advisory Group IPC services and pandemic preparedness, Leila Hail Federation oFlnfection Societies In March 2021 HIS, 81A and MS implemented a Risk policy new framework for hosting the annual hybrid FIS HIS is committed to maintaining a strong risk- International Conference. Each Society will hosl the management fvamework, The Society's policy annual hybrid FIS event in an agreed rotation. The enables constructive risk mitigation. management BIA and MS will host a FIS conference every Four years and response. Specific roles are delegated between IBIA in 2021 and MS in 20231. H15 will continue to trustees and senior management to attribute specific host an international conference every two years and Dwner5hip and responsibility. The policy 15 reviewed the conference will branded as a FIS/H15 International annually to ensu￿ relevance. Council have ag￿ed 12022 and 20241. Key to the success of F15 is the that, with real or perceived changes in futu￿ income unique breadth and range OF communities that participate, and the cross-Ferfilisation that occurs between different networks and membership groups. The hosting societies will aim to continue to develop multidisciplinary educational opportunities. In 2022 FiS/HIS International will take place as a two- day live event122 and 23 September} at the Business Design Centre in London and a one-day Fully virtual event on 26 september. Risks and uncertainties The trustees have examined the majorrisks the Society Faces and conflrm that systems and policies have been èstablished to ensure necessary steps can be taken to manage or miligate anysuch risks. FEDERATION INFECTION SOCIETIES London 22- 23 September Virtual 26 September FISIHIS International 2022 Hosted by the Healthcare Infection Society 33

Healthcare Infection Society Annual Report

opportunities, a risk-based reserves model is a more appropriate method to safeguard future Society �nancial sustainability, and a policy to this e�ect will be developed over the forthcoming �nancial year.

Risk register

An extensive risk register is consistently maintained and reviewed in full by Council on an annual basis. Signi�cant risks and quarter-on-quarter changes are identi�ed using a heat map and any organisational impact is monitored through key performance indicators. Anyrevisions andallcontinuingoremerging risks rated of high concern, or risks where there is any signi�cant or sudden anticipated change, are reported at each meeting of Council to determine priority action where this is required.

Incidents which are considered to pose a signi�cant threat to the charity, �nancial or otherwise, are immediately escalated to Council. The impact of COVID-19 and the more recent monkeypox outbreak on HIS activities has both contributed to the development and proven the e�ectiveness of the risk register as an e�ective management tool within the Society.

Principle risks

Income

The trustees recognise that the activities of the Society in providing support for scienti�c research and education are principally reliant on the income it receives from the JHI. Support to ensure the continuing success of the journal is therefore a critical function of HIS Council. The Editorial and Production Manager, a rolewithin the internalsta�ng structure, alongside the editors, is responsible for the strategic development of the JHI.

The trustees are currently evaluating alternative forms of income diversi�cation and generation through both existing and additional activities.

Through its delegated funds and reserves policy, the Society maintains appropriate �nancial investments to ensure that it can fully support its charitable activities, and to remain a going concern.

COVID-19

COVID‐19 presented an unexpected, uncertain and unprecedentedriskto boththe�nances andoperations of the organisation. Managed through the risk policy and register, the risks associated with the pandemic have been continuously assessed throughout 2021 and 2022, with mitigation policies established in investments, income generation, conferences and events, publishing and sta�welfare, as well as to the operational support provided within these areas.

Income diversi�cation

Income diversi�cation remains key to the ongoing �nancial stability of the Society, and therefore a principle risk.

Strategic investment in activities underpinning the generation of income through diversi�cation are supported through the Future Sustainability Delegated Fund as well as through the proposed development ofa risk-based reserves model.

With HIS Council approval the Society have embarked on an e-learning strategy, focused on the development of HIS Courses for delivery within a new learning managementsystem.Theinitialcourseisplannedtogo live in March 2023. In 2022 HIS Council agreed on the formation ofa Finance Committee, one aspect ofwhich will be to oversee the future �nancial sustainability of the Society.

Other principle risks

The trustees are aware of the research undertaken by the Fraud Advisory Panel on the extent of fraud in the charity sector and recognise that fraud must be covered in the Society’s risk management processes.

The trustees support health and safety risk management with the intention of providing a modern and safe environment in which to work. The strategy is to identify hazards and risks within the Society’s premises and to control, eliminate or reduce to an acceptable level all risks which have an adverse e�ect on the ability of sta�, members and visitors to work within the premises. The trustees are aware of additional obligations arising from the Charities (Protection and Social Investment) Act 2016 and are implementing measures to ensure compliance.

34

For the year ended 31 March 2022

Challenges during the year

Sta�home working and wellbeing

HIS supports sta�development and welfare through rolling assessments, annual appraisals, focused training, employee assistance programmes, bene�t platforms and social engagement. During the year the entire HIS sta�team moved to working in a hybrid format, where all team members work from Montagu House on the same two days each week, and from home thereafter.

Volunteer engagement

The development and delivery of the majority of the Society’s activities rely heavily on the input of our volunteers as experts in nosocomial infections and IPC. During the COVID-19 outbreak, study leave for much of the IPC workforce was cancelled, and the sheer demands of work during this period and afterwards meant thatvolunteers did not have the capacityto help the Society to deliver activities to planned levels.

Cancelled events

Many of the Society’s face-to-face events during the period of this report were cancelled and replaced, where possible, with online versions of the events.

Face-to-face events returned on 16 September 2021 with an Outbreaks Training Course held at Montagu House with reduced delegate numbers and COVID-19 restrictions in place.

New premises

HIS completed the purchase of new premises, Montagu House in Wake�eld Street, London, in March 2020, approximately two weeks prior to the �rst COVID-19 lockdown. The building has three �oors. Approximately 40% of one �oor is utilised as the HIS headquarters, with the remaining 60% as commercial space to create an income stream through letting. The building was purchased as a shell and core, with headquarters �t out managed through the pandemic and successfully completed in August 2020.

The impact of COVID-19 led to some delays in bringing the building into use, with HIS sta�working on a hybrid basis from September 2021, and commercial tenants occupying the additional two �oors from February 2022.

Remuneration and grant making

The roles and contribution of volunteers

In principle, members and O�cers of Council conduct the business of the Society, with the exception of editorial and convenor services, on a voluntary basis.

WhileO�cersdonotpersonally�nanciallybene�tfrom their role in the Society, where they are unable to carry out their duties because of professional commitments, the Society has an option to compensate their trust or employer for the time necessary to ful�l their duties.

Following advice from the NCVO and the Society’s auditor, Moore Kingston Smith, this is a change from previous policy where O�cers’ employers were compensated as a matter of routine, and was unanimously voted and agreed by Council in the meeting of 11 September 2019. Details of such payments can be found in note 9 of the accounts. No O�cers’ employers have been remunerated since November 2021.

Other HIS volunteers include members of Working Parties, and HIS representatives on the committees of other organisations. All members of Council and other volunteers are entitled to reimbursement of expenses as outlined in the Travel and Expenses Policy. This Policy is intended to ensure that expenses are kept to a minimum.

Lay member payment policy

To enable the recruitment and involvement of a diverse cross section of the public and patients as lay representatives, in March 2020 the trustees agreed to bring the Society’s payment and expenses policyfor lay members in line with recommendations from NICE and the National Institute for Health and Care Research. This policy allows for claims of out-of-pocket expenses and honoraria.

35

Healthcare Infection Society Annual Report

Conveyor contracts

Through an agreement with UKHSA, HIS engages the services of Karren Staniforth as convenor for both Engineering Aspects of Infection Control courses and for the HIS/UKHSA Foundation courses.

Remuneration Committee

The Remuneration Committee was established in April 2019 and is comprised of the Chair of Trustees, the Treasurer and the Lay Trustee. The primary responsibilities of the Remuneration Committee are to make recommendations to Council on sta� pay awards and on the performance-related pay scheme. If required, payments to trustees or employer compensation payments are discussed.

In this �nancial year the Committee reviewed the remuneration of the CEO and approved the annual sta�pay review.

Key management personnel remuneration

The Society considers that its key management personnel comprises the trustees, the CEO and the entire sta�team. The policy and procedure in determining the remuneration payable to the CEO and all sta�is as agreed by all the trustees following recommendations made by the Remuneration Committee. The rate of remuneration for all sta�is benchmarked against organisations of a similar size and activity.

All trustees give of their time freely and no trustee received any remuneration or other employee bene�ts for their role as trustee. As outlined in the ‘Roles and contributionofvolunteers’section earlierinthis report, the Society has an option to compensate trustees’ trust or employer for the time necessary to ful�l their duties.

career-development opportunities which are pertinent to IPC, including epidemiology and prevention. The applicant’s aims must be clearly stated, and the research must be hypothesis driven, where applicable. All applications enter a triage process before being reviewed in a robust and transparent process by the Research Committee. Where applicable, shortlisted applications also undergo external peer review with leading experts.

The award of grants carries several conditions:

Selection of social, or programme, related investments

In addition to regular grants, the Society may, from time to time, award additional funds for activities which are aligned with HIS aims and objectives. Such awards will be discussed and approved or refused by the members of Council on presentation of a fullycosted application which includes aims, objectives and intended outcomes.

Details of trustee expenses and related party transactions are disclosed in notes 9, 18 and 19 to the accounts.

Grant-making policy

Grants and fellowships are awarded for research and

36

For the year ended 31 March 2022

Statement of trustees’ res onsibilities p

The trustees are responsible for preparing the Trustees’ Report and the �nancial statements in accordance with applicable legislation and regulations. The law applicable to charities in England and Wales requires trustees to prepare �nancial statements for each �nancialyearwhichgive atrue and fairviewofthe state of a�airs of the charity and of its incoming resources and the application of resources of the charity for that period. The trustees have elected to prepare the �nancial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). ln preparing these �nancial statements, the trustees are required to:

The trustees have taken all steps that they ought to have taken to make them aware of any relevant audit information and to establish that the auditor is aware of that information.

The trustees are responsible for the maintenance and integrity of the charity and �nancial information included on the charity’s website. Legislation in the United Kingdom governing the preparation and dissemination of �nancial statements may di�er from legislation in other jurisdictions.

Approved by the trustees on 21 September 2022, and signed on their behalf by:

D.Harvey (Nov 3, 2022 11:19 GMT)

Dr David Harvey, HIS Treasurer

The trustees are responsible for keeping adequate accounting records that are su�cient to explain the charity’s transactions and disclose with reasonable accuracy at any time the �nancial position of the charity and enable them to ensure that the �nancial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the charity’s Constitution.

Theyare also responsible forsafeguarding the assets of the charity and group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

ln so far as the trustees are aware:

37

Healthcare Infection Society Annual Report

Independent auditor’s report to the trustees of the Healthcare Infection Societ y

Opinion

Wehave audited the �nancialstatements ofHealthcare Infection Society (‘the charity’) for the year ended 31 March 2022which comprise the Statement ofFinancial Activities, the Balance Sheet, the Cash Flow Statement and notes to the �nancial statements, including a summary of signi�cant accounting policies. The �nancial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice).

In our opinion the �nancial statements:

Basis for opinion

WeconductedourauditinaccordancewithInternational

Standards on Auditing (UK) (ISAs(UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the audit of the �nancial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the �nancial statements in the UK, including the FRC’s Ethical Standard, and we have ful�lled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidencewe haveobtainedissu�cientandappropriate to provide a basis for our opinion.

Conclusions relating to going concern In auditing the �nancial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the �nancial statements is appropriate.

Based on the work we have performed, we have not identi�ed any material uncertainties relating to events or conditions that, individually or collectively, may cast signi�cant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the �nancial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the �nancial statements and our auditor’s report thereon. The trustees are responsible for the other information. Our opinion on the �nancial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Inconnectionwithourauditofthe�nancialstatements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the �nancial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the �nancial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

38

For the year ended 31 March 2022

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Charities Act 2011 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement set out on page 37, the trustees are responsible for the preparation of the �nancial statements and for being satis�ed that they give a true and fair view, and for such internal control as the trustees determines is necessary to enable the preparation of �nancial statements that are free from material misstatement, whether due to fraud or error.

In preparing the �nancial statements, the trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charity or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the �nancial statements

We have been appointed as auditor under section 144 ofthe Charities Act 2011 and report in accordancewith regulations made under section 154 of that Act.

Our objectives are to obtain reasonable assurance about whether the �nancial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in aggregate,

they could reasonably be expected to in�uence the economic decisions ofusers taken on the basis ofthese �nancial statements.

As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

39

Healthcare Infection Society Annual Report

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and signi�cant audit �ndings, including anysigni�cant de�ciencies in internal control that we identify during our audit.

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of noncompliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the �nancial statements due to fraud; to obtain su�cient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identi�ed during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the charity.

Our approach was as follows:

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances ofnon-compliance with laws and regulations that are not closely related to events and transactions re�ected in the �nancial statements. Also, the risk of not detecting a material misstatement due to fraud is higher than the riskof not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

Use of our report

This report is made solely to the charity's trustees, as a body, in accordance with Chapter 3 of Part 8 of the Charities Act 2011. Our audit work has been undertaken so that we might state to the charity’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted bylaw, we do not accept or assume responsibility to any party other than the charity and charity's trustees as a body, for our audit work, for this report, or forthe opinionwe have formed.

Neil Finlayson (Senior Statutory Auditor)

for and on behalf of

Moore Kingston Smith LLP, Statutory Auditor 9 Appold Street, London EC1A 2AP

Date:

Moore Kingston Smith LLP is eligible to act as auditor in terms of Section 1212 of the Companies Act 2006.

40

Healthcare Infection Society

For the year ended 31 March 2022

Statement of �nancial activities for the ear ended 31 March 2022 y

Unrestricted Unrestricted
Notes Funds General Funds Designated Total Funds 2022 Total Funds 2021
Income from: £ £ £ £
Charitable activities
Membership 51,732 ‐ 51,732 39,404
Education 2 110,870 ‐ 110,870 3,970
Publications 3 618,563 ‐ 618,563 595,696
Conferences 4 7,600 ‐ 7,600 146,105
Investments
Interest and dividends 5 110,355 ‐ 110,355 100,054
Property income 16,314 ‐ 16,314 ‐
Other income ‐ ‐ ‐ 24
Total income 915,434 ‐ 915,434 885,253
Expenditure on:
Cost of raising funds
Investment management fees (905) - (905) 1,168
Charitable activities
Awards and grants 58,255 99,217 157,472 89,640
Membership 78,782 67,567 146,349 131,658
Education 86,104 96,168 182,272 63,125
Publications 102,263 65,943 168,206 168,646
Communication 76,314 14,035 90,349 80,873
Conferences 80,059 13,301 93,360 146,877
Research and guidelines 174,949 47,759 222,708 202,286
Total charitable expenditure 6 656,726 403,990 1,060,716 883,105
Total expenditure 655,821 403,990 1,059,811 884,273
Transfers between funds (281,990) 281,990 ‐ ‐
Net investment gains / (losses) (9,630) - (9,630) 442,263
Net income and net movement
in funds for the year		 (32,007) (122,000) (154,007) 443,243
Fund balances brought
forward at 1 April		 785,126 8,409,000 9,194,126 8,750,883
Fund balances carried
forward at 31 March		 753,119 8,287,000 9,040,119 9,194,126

All the above results were derived from continuing activities.

The notes and information on pages 44 to 51 form part of these �nancial statements.

41

Healthcare Infection Society Annual Report

Balance sheet as at 31 March 2022

Notes
Fixed assets
Tangible assets
10
Intangible assets
11
Quoted investments
12
Property investment
13
Current assets
Debtors
14
Short term deposits
Cash at bank and in hand
Creditors:amounts falling due within one year
15
Net current assets
Creditors:amounts falling after more than one year
15
Net assets
16
Restricted funds
Unrestricted funds:
General fund
17
Designated funds
17
Total funds
Approved by the Board of Trustees on 21 September 2022
and signed on its behalf by:		 2022
2021
£
£
2,863,239
4,422,172
-
9,834
4,173,366
4,181,825
1,471,444
-
8,508,049
8,613,831
249,017
357,993
2
266
966,521
877,677
1,215,540
1,235,936
519,893
493,231
695,647
742,705
163,577
162,410
9,040,119
9,194,126
753,119
785,126
8,287,000
8,409,000
9,040,119
9,194,126

D.Harvey (Nov 3, 2022 11:19 GMT) Dr David Harvey HIS Treasurer

The notes and information on pages 44 to 51 form part of these �nancial statements.

42

Healthcare Infection Society

For the year ended 31 March 2022

Statement of cash �ows for the year ended 31 March 2022

Notes
Cash �ows from operating activities:
Net cash used in operating activities
Cash �ows from investing activities:
Interest and dividends from investments
Interest on bank deposit accounts
Proceeds from the sale of �xed assets
Purchase of �xed assets
Proceeds on sale of investments
Additions to investment portfolio
Net cash generated through investing activities
Change in cash and cash equivalents in the reporting period
Cash and cash equivalents at the beginning of the reporting period
Cash and cash equivalents at the end of the reporting period
Reconciliation of net expenditure to net cash �ow
from operating activities
Gain after other recognised gains and losses
Net investment (gains) / losses
Net gains on the sale of �xed assets
Depreciation of tangible �xed assets
Amortisation of intangible �xed assets
Decrease / (increase) in debtors
(Decrease) / increase in creditors
Investment income
Cash �ow from operating activities
Analysis of cash and cash equivalents
Cash in hand
Short term deposits
Total cash and cash equivalents		 2022
2021
£
£
(6,999)
660,924
110,273
98,903
82
1,151
-
-
(13,605)
(194,464)
538
501,489
(1,709)
(2,000,055)
95,579
(1,592,976)
88,580
(932,052)
877,943
1,809,995
966,523
877,943
(154,007)
443,243
9,630
(442,263)
-
-
101,094
58,076
9,834
19,668
108,976
886,322
27,829
(204,068)
(110,355)
(100,054)
(6,999)
660,924
966,521
877,677
2
266
966,523
877,943

The notes and information on pages 44 to 51 form part of these �nancial statements.

43

Healthcare Infection Society Annual Report

Notes to the accounts for the year ended 31 March 2022

1. Accounting policies

The principal accounting policies adopted by the Society are as detailed below:

a) Basis of preparation

The �nancial statements have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant note(s) to these �nancial statements. The �nancial statements have been prepared in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (e�ective 1 January 2015) (Charities SORP (FRS102)), and the Charities Act 2011.

Healthcare Infection Society meets the de�nition of a public bene�t entity as de�ned by FRS102.

are allocated to the Statement of Financial Activities on the basis of sta�time spent on each area of activity.

Costs of raising funds comprise investment managers’ fees.

Charitable activities expenditure includes services supplied identi�able as wholly or mainly in support of the Society’s objectives and includes grants payable.

d) Grants payable

Grants are made to institutions and individuals for training, research and travel and are charged to the Statement of Financial Activities when authorised by the Board of Trustees and communicated to the recipient.

The provision for a multi‐year grant is recognised at its transaction value and is not discounted, given that discounting is not material to the �nancial statements.

e) Investments

The trustees have assessed whether the use of the going concern basis is appropriate and have considered possible events or conditions that might cause signi�cant doubt on the ability of the charity to continue as a going concern. In particular the trustees have considered the charity’s forecast and projections having taken account of the COVID‐19 pandemic. Whilst an operational de�cit is forecast for the years to 31 March 2023 and 2024, the trustees gain assurance that that the charity has signi�cantly healthy reserves and cash funds as at the year end. The Society has created a £3m designated fund speci�cally to o�set such de�cits, and to invest in future income generation strategies to mitigate these going forward. The trustees are therefore satis�ed the charity has adequate resources to continue in operation for at least twelve months from the approval of the �nancial statements. The charity continues to adopt the going concern basis in preparing its �nancial statements.

b) Income recognition

All income is recognised once the charity has entitlement to the income, it is probable, and that the income will be received and that the amount of income receivable can be measured reliably.

Voluntary income including donations, investment income and income from charitable activities including membership, journal and conference income are shown in the �nancial statements on a receivable basis. Income received that relates to a subsequent �nancial accounting period is carried forward as a credit in the Balance Sheet and shown as deferred income.

c) Expenditure recognition

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that settlement will be required, and the amount of the obligation can be measured reliably.

Investments are a form of basic �nancial instrument and are initially recognised at their transaction value and subsequently measured at their fairvalue as at the Balance Sheet date using the closing quoted market price. The Statement of Financial Activities includes the net gains and losses arising on the revaluation and disposals throughout the year.

The Society does not acquire put options, derivatives or other complex �nancial instruments.

The main form of �nancial risk faced by the Society is that of volatility in equity markets and investment markets due to wider economic conditions, the attitude of investors to investment risk and changes in sentiment concerning equities and within particular sectors or sub‐ sectors.

f) Gains/losses on investment assets

All gains and losses are taken to the Statement of Financial Activities as they arise.

Unrealised gains and losses on investment assets represent the di�erence between their fair value at the end of the year and their fairvalue at the beginning of the year, or transaction value if acquired during the year.

Realised gains and losses on disposal of investment assets represent the di�erence between the sale proceeds and the fairvalue at the beginning of the year, or transaction value if acquired during the year.

g) Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated at the rate of exchange ruling at the Balance Sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All di�erences are taken to the Statement of Financial Activities.

h) Cash and cash equivalents

Expenditure is recognised on an accruals basis, that is, in the period in which the liability is incurred. Support costs are those costs attributable to a speci�c activity and

Cash and cash equivalents include cash and cash at banks and in hand and short term deposits with a maturity date of three months or less.

44

Healthcare Infection Society

For the year ended 31 March 2022

Notes to the accounts for the year ended 31 March 2022 (cont.)

i) Irrecoverable value added tax

Irrecoverable value added tax on purchases and expenses is charged as an expense.

j) Tangible �xed assets

Tangible �xed assets of a value of £500 and over are capitalised, and are stated at cost less accumulated depreciation.

Assets Under Construction are accounted at their purchase cost and are not depreciated until the asset comes into use.

Depreciation is charged so as to write o�the full cost, less any residual value, over the economic life of the asset at the following annual rates:

Tangible �xed assets: Land and buildings 2% straight line Computer equipment 33% straight line Fixtures and �ttings 15% straight line

k) Intangible �xed assets

The cost of developing the Content Management System (CMS) and Customer Relationship Management (CRM) systems were considered a signi�cant investment in Society infrastructure and have been capitalised as an intangible asset.

n) Operating leases

Rentals payable under operating leases, where substantially all the risks and rewards of ownership remain with the lessor, are charged to the Statement of Financial Activities on a straight line basis over the lease duration. Contingent rentals arising under operating leases are recognised as an expense in the period in which they are incurred.

o) Financial Instruments

The Society only has �nancial assets and liabilities of a kind that qualify as basic �nancial instruments. Basic �nancial instruments are initially recognised at transaction value and are subsequently measured at amortised cost using the e�ective interest method.

p) Critical accounting estimates and areas of judgement In preparing �nancial statements it is necessary to make certain judgements, estimates and assumptions that a�ect the amounts recognised in the �nancial statements. In the view of the trustees in applying the accounting policies adopted, no judgements were required that have a signi�cant e�ect on the amounts recognised in the �nancial statements nor do any estimations or assumptions made carry a signi�cant risk of material adjustment in the next �nancial year.

Intangible �xed assets are stated at cost less accumulated amortisation.

Amortisation is charged so as to write o�the full cost, less any residual value, over the economic life of the asset at the following annual rates:

Intangible �xed assets: Systems development 33% straight line

l) Fund accounting

General funds are unrestricted funds used for furthering the objects of the Society.

Designated funds are unrestricted funds which have been set aside by the trustees at their discretion for speci�c purposes as shown in note 17.

m) Employee bene�ts

i. Short term bene�ts

Short term bene�ts, including holiday pay and other similar non‐monetary bene�ts, are recognised as an expense in the period in which the service is received.

ii. Pension costs

The Society operates a de�ned contribution pension scheme. Contributions are charged to the Statement of Financial Activities in the year in which they fall due.

At the year end contributions totalling £3,960 (2020: £3,967) were outstanding.

45

Healthcare Infection Society Annual Report

Notes to the accounts for the year ended 31 March 2022 (cont.)

2022 2021
£ £
2. Education income
Foundation course 72,200 -
Engineering aspects course 16,995 -
DIPC educational programme 8,750 -
Trainee educational programme 2,000 1,470
Guidelines developer course 5,575 1,500
Outbreaks workshop 1,350 -
Webinars 4000 1,000
110,870 3,970
3. Publications income
Journal of Hospital Infection 600,003 578,507
Infection Prevention in Practice 18,560 17,189
618,563 595,696
4. Conferences income
FIS HIS 2020 -
HIS Spring Meeting -
Don't Panic 7,600
Bridging the gap -
7,600 146,105
5. Investment income
Interest and dividends from investments 110,273 98,903
Interest on cash deposits 82 1,151
110,355 100,054
6. Expenditure on charitable activities Direct costs Sta�costs Support costs Total 2022 Total 2021
£ £ £ £ £
Awards and grants 91,457 47,433 18,582 157,472 89,640
Membership 54,266 60,227 31,855 146,348 131,658
Education 75,107 56,728 50,438 182,273 63,125
Publications 51,683 82,013 34,510 168,206 168,646
Communications 1,842 59,306 29,201 90,349 80,873
Conferences 1,278 60,227 31,855 93,360 146,877
Research and guidelines 18,944 134,744 69,020 222,708 202,286
Total charitable expenditure 294,577 500,678 265,461 1,060,716 883,105

a. Support costs

Support costs
Support costs are allocated on the basis of sta�time and comprise the following:
Repairs and premises costs
Bank charges
Depreciation and amortisation charges
O�ce, legal and administrative expenses
Irrecoverable VAT
Governance costs (see (b) below)		 2022
2021
£
£
39,816
39,074
3,319
3,487
110,848
77,744
64,756
64,638
4,896
741
41,826
45,928
265,461
231,612

46

Healthcare Infection Society

For the year ended 31 March 2022

Notes to the accounts for the year ended 31 March 2022 (cont.)

2022 2021
£ £
b. Governance costs
Council expenditure 31,256 32,028
Audit 10,570 13,900
41,826 45,928
7. Investment gains / (losses)
Realised - 267
Unrealised (9,630) 441,996
(9,630) 442,263
8. Grants awarded
Dr Kate Walker Research - 9,969
Dr Sarah Forbes Research - 9,990
Dr Razan Saman Research - 62,502
Dr Benjamin Parcell Early career award - 1,000
Dr Andrew Kirby Research 87,852 -
Mr Harry Dean Research 10,000 -
Dr Poonam Kapila Career Development Bursary 1,200 -
Dr Nicola Baldwin Public Engagement Grant 1,015 -
Dr David Eyre Early career award 1,000 -
101,067 83,461
9. Employers remuneration
The average number of persons employed by the charity during the
year for the purpose of charitable activities was 8 (2021: 8).
The aggregate payroll costs of these persons were as follows:
Wages and salaries 407,294 365,433
Social security 42,526 37,952
Employer pension contributions 24,161 23,023
473,981 426,408
2 employees received total employee bene�ts (excluding pension and national insurance
contributions) of more than £60,000 in the year under review (2021: 2).
The number of employees receiving salaries within the following bands: 2022 2021
£60,001 to £70,000 - 1
£70,001 to £80,000 1 1
£80,001 to £90,000 1 -

The Society considers its key management personnel

comprises the CEO, Kay Miller, and the trustees. Kay Miller received salary and employer pension and national insurance contributions within this period of £96,876 (2021: £94,980).

No trustee received any remuneration or other employee bene�ts for their role as trustee during the year.

However, the employers of the trustees have invoiced the charity for additional services performed as follows:

Dr Elisabeth Ridgway became Chair of the Society in November 2015 and resigned November 2021. Payments

due during the year to her employer, She�eld Teaching Hospitals NHS Trust, amounted to £8,202 (2021: £8,158).

Dr Peter Jenks became Secretary of the Society in November 2015 and retired November 2021. Estimated payment due during the year to his employer, Plymouth Hospitals NHS Trust, amounted to £13,600 (2021: £20,000).

Dr Jim Gray has been the Society Editor in Chief since February 2015. During the year payments due for his services, including employers NI, amounted to £10,615 (2021: £10,623).

47

Healthcare Infection Society Annual Report

Notes to the accounts for the year ended 31 March 2022 (cont.)

10. Tangible �xed assets
Cost:
At 1 April 2021
Additions
Cost adjustment
Disposals
Transfers
At 31 March 2022
Depreciation:
At 1 April 2021
Provision in the year
Disposals
At 31 March 2022
Net bookvalue:
At 31 March 2022
At 31 March 2021
11. Intangible �xed assets
Cost:
At 1 April 2021
Additions
At 31 March 2022
Amortisation:
At 1 April 2021
Provision in the year
At 31 March 2022
Net bookvalue:
At 31 March 2022
At 31 March 2021		 Fixtures
and �ttings
Computer
equipment
Freehold
land
Freehold
buildings
Total
£
£
£
£
£
318,407
12,702
1,680,000
2,477,023
4,488,132
5,430
8,175
-
-
13,605
-
-
-
-
-
-
(5,702)
-
-
(5,702)
-
-
-
(1,471,444)
(1,471,444)		 Fixtures
and �ttings
Computer
equipment
Freehold
land
Freehold
buildings
Total
£
£
£
£
£
318,407
12,702
1,680,000
2,477,023
4,488,132
5,430
8,175
-
-
13,605
-
-
-
-
-
-
(5,702)
-
-
(5,702)
-
-
-
(1,471,444)
(1,471,444)
323,837
15,175
1,680,000
1,005,579
3,024,591
27,860
9,201
-
28,899
65,960
48,213
3,261
-
49,540
101,014
-
(5,622)
-
-
(5,622)
76,073
6,840
-
78,439
161,352
247,764
8,335
1,680,000
927,140
2,863,239
290,547
3,501
1,680,000
2,448,124
4,422,172
Systems
development
Total
£
£
59,005
59,005
-
-
59,005
59,005
49,171
49,171
9,834
9,834
59,005
59,005
-
-
9,834
9,834

48

Healthcare Infection Society

For the year ended 31 March 2022

Notes to the accounts for the year ended 31 March 2022 (cont.)

12. Quoted investments
Quoted investments market value:
At 1 April
Additions
Disposals at market value
Gains / (losses) in the period
Market value as at 31 March
Historic cost
Quoted investments analysis at market value:
UK �xed interest securities
Equity UK
Equity global
Property
Alternative investments
Liquid assets
Market value as at 31 March		 2022
2021
£
£
4,181,825
2,240,996
1,709
2,000,055
(538)
(501,489)
(9,630)
442,263
4,173,366
4,181,825
3,797,056
3,795,885
1,024,174
1,195,979
681,337
618,182
1,355,932
1,482,185
138,679
59,158
525,231
309,053
448,013
517,268
4,173,366
4,181,825

All quoted investments are carried at their fairvalue.

Investments in bonds, equities, property and alternative investments are all traded in quoted public markets, primarily the London Stock Exchange. The basis of fairvalue for quoted investments is equivalent to the market value, using midmarket price. Asset sales and purchases are recognised at the date of trade at cost (i.e. their transaction value).

For the remaining investments, the signi�cance of �nancial instruments to the ongoing �nancial sustainability of the Society is considered in the �nancial review and investment policy and performance sections of the Trustees’ Report.

The main risk to the Society from �nancial instruments lies in the combination of uncertain investment markets and volatility in yield. The Society is reliant on dividend yield in part to �nance its work and this leads to greater exposure to international companies, the values ofwhich, together with theiryield are exposed to exchange rate riskwhen converting the holdings into sterling.

The Society manages these investment risks by retaining expert advisers and operating an investment policy that provides for a high degree of diversi�cation of holdings within investment asset classes that are quoted on recognised stock exchanges.

The Society does not make use of derivatives and similar complex �nancial instruments as it takes the view that investments are held for their longer term yield total return.

13. Investment property

Historic cost

During the year to 31 March 2020, a signi�cant proportion of Society investments previously held as liquid assets were utilised for the purchase of a new building, Montagu House. This purchase is now complete and for the �nancial statements to 31 March 2021 the property has been accounted for in its entirety as freehold property within tangible �xed assets.

A proportion of Montagu House is excess to operational requirement and from 14 February 2022 this proportion has been let on a commercial basis at market rate.

For the �nancial statements to 31 March 2022, the value of the nonoperational element has been transferred from tangible �xed assets and recognised as investment assets at historic cost.

During the forthcoming �nancial year the Society will seek an independent valuation, in accordance with the requirements of the RICS Valuations Standards and FRS 102, and recognise this asset at fairvalue.

49

Healthcare Infection Society Annual Report

Notes to the accounts for the year ended 31 March 2022 (cont.)

14. Debtors
Trade debtors
Taxes
Other debtors
Prepayments and accrued income
15. Creditors – amounts falling due within one year
Trade creditors
Accruals
Grants
Taxes and social security
Deferred income
Other creditors		 2022
2021
£
£
42,523
173,331
-
-
8,667
11,949
197,827
172,713
249,017
357,993
41,527
17,145
131,482
116,244
189,351
234,276
52,269
39,604
103,430
84,799
1,834
1,163
519,893
493,231

Creditor amounts falling due after more than one year relate to grants payable of £163,577 (2021: £162,410)

Reconciliation of deferred income
Balance as at 1 April 2021
Amounts released to income earned from charitable activities
Amounts deferred in the year
16. Analysis of net assets between funds
Tangible �xed assets
Intangible �xed assets
Quoted investments
Property investments
Debtors
Short term deposits
Cash at bank and in hand
Creditors falling due within one year
Creditors falling due after more than one year
Net assets at 31 March 2022		 84,799
201,400
(84,799)
(201,400)
103,430
84,799
103,430
84,779
2,863,239
4,422,172
-
9,834
4,173,366
4,181,825
1,471,444
-
249,017
357,993
2
266
966,521
877,677
(519,893)
(493,231)
(163,577)
(162,410)
9,040,119
9,194,126

For the purpose of these accounts, all Society funds are unrestricted

50

Healthcare Infection Society

For the year ended 31 March 2022

Notes to the accounts for the year ended 31 March 2022 (cont.)

1 April 31 March 31 March
17. Funds 2021 Income Expenditure Gains Transfers 2022 2021
£ £ £ £ £ £ £
Unrestricted funds
General 785,126 915,434 (655,821) (9,360) (281,990) 753,119 785,126
Designated funds
Grants Reserve 675,000 - (91,457) - 58,457 642,000 675,000
Other Society Activities 302,000 - (201,685) - 209,685 310,000 302,000
Fixed Assets 32,000 - (13,095) - (10,905) 8,000 32,000
Montagu House 4,400,000 - (97,753) - 24,753 4,327,000 4,400,000
Future Sustainability Fund 3,000,000 - - - - 3,000,000 3,000,000
Total designated funds 8,409,000 - (403,990) - 281,990 8,287,000 8,409,000
Restricted funds - - - - - - -
Total funds 9,194,126 915,434 (1,059,811) (9,360) - 9,040,119 9,194,126

The designated funds are set up for the following purposes:

Grants Reserve: Represents the balance of grants awarded with stage payments yet to be paid, together with planned awards for the next �nancial year to ensure the continued funding of Research and other Grants for the forthcoming �nancial year.

Other Society Activities: Represents the value required to protect and enable the ongoing funding of Society Activities for the next �nancial year, with the exception of the grants and conferences forwhich funds have been designated separately.

Fixed Assets Fund: Represents the value invested in tangible �xed assets to enable the ongoing operations and activities of the Society.

Montagu House: Represents the net bookvalue of Montagu House as at 31 March 2022, being an investment, both for HIS headquarters and for the generation of income through commercial lettings.

Future Sustainability Fund: Represents funds set aside to meet planned future de�cit budgets, as well as to facilitate investment within income generating initiatives.

The undesignated funds are used for operational costs within the Society.

Transfers between the unrestricted and designated funds during the year represent the changing requirement for funds in line with Society strategy and operations as agreed by the Trustees.

18. Related party transactions

There were no related party transactions during the year (2021: None).

19. Trustees

The trustees received no remuneration for their role as trustees. In the year to 31 March 2022, 7 trustees were reimbursed a total of £1,837 for expenses incurred in respect of travel and subsistence. (2021: £nil to 0 trustees).

20. Capital commitments

The Society had no capital commitments as at 31 March 2022. (2021: £nil).

51

Healthcare Infection Society Annual Report

Reference and administrative information

Registered name: Healthcare Infection Society
Registered number: 1158172
Registered o�ce address: Montagu House, 7E Wake�eld Street London, WC1N 1PG
Council member Appointment Appointed Term of o�ce Completed
Professor Hilary Humphreys President Nov 2018 Current
Dr Elisabeth Ridgway Chair Nov 2015 AGM 2021
Dr Peter Jenks Secretary Nov 2015 AGM 2021
Dr Manjula Meda Ordinary member
Secretary		 Nov 2020
Nov 2021		 Current AGM 2021
Dr Christopher Settle Treasurer
Chair		 Jun 2020
Nov 2021		 Current AGM 2021
Dr David Harvey Treasurer Nov 2021 Current
Dr Jim Gray Editor in Chief JHI Feb 2015 Current
Dr Emma Boldock Ordinary member
Chair: Research Committee		 Nov 2016 Current (term extended
to AGM 2022)
Dr James Price Ordinary member
Chair: Professional
Development Committee		 Nov 2018 Current (term extended
to AGM 2022)
Dr Joanna Walker Ordinary member
Chair: Trainee Committee		 Nov 2019 Current (term extended
to AGM 2023)
Dr Gemma Wheldon Ordinary member Feb 2018 Current (term extended
to AGM 2022)
Ron Finlay Lay trustee Nov 2021 Current
Leila Hail **Co-opted member
(Infection Control Nurse)		 Nov 2021 Current
Dr Luke Moore Ordinary member Nov 2020 Current
Dr Gayti Morris Ordinary member Nov 2020 Current
Andrea Parsons Lay trustee Feb 2018 AGM 2021
Dr Shanom Ali **Co-opted member
(Clinical Scientist)		 Nov 2020 AGM 2021
Trustee Nov 2021 Current
Claire Haill **Co-opted member
(Infection Control Nurse)		 Mar 2018 AGM 2021
Professor Peter Wilson **Co-opted member
Chair: Guidelines Committee		 Nov 2013 Current

** Chairs and Co-opted members are not trustees unless they are also Ordinary members.

All Ordinary Members of Council are trustees. There are additional members of Council co-opted on a discretionary basis as per clause 4(14) of the Constitution. Co-opted members are not trustees and may not vote at Council meetings, but theyprovidevaluable additional experience from across healthcare professions.

52

Chief Executive O�cer: Dr Kay Miller Bank: Barclays Bank plc, PO Box 12820 1250 High Road Whetstone London N20 0PB Auditor: Moore Kingston Smith LLP 9 Appold Street London EC2A 2AP Investment fund manager: Sarasin & Partners LLP Juxon House 100 St. Paul’s Churchyard London EC4M 8BU Solicitors: Radcli�esLeBrassier 85 Fleet Street London EC4Y 1AE Human resources: Peninsula Business Services Ltd The Peninsula Victoria Place Manchester M4 4FB

©2022 Healthcare Infection Society (HIS). All rights reserved. Registered Charity Number: 1158172

Healthcare • • InFection Society Healthcare Infection Society {HlS) his.org.uk | admin8his.org.ukl 020 7713 0273 | W 8HIS_inFection Montagu House, 7EWakefield Streel, London, WC1 N 1 PG